Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Huntington's disease
Economic impact of diagnostic testing
8 evidence topics · 10 sources
Cost of predictive genetic testing at HDSA Centers of Excellence in the United States
Predictive testing uptake among at-risk individuals
“9407 predictive tests were performed across 23 UK centres.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Using a prevalence figure of 12.3 × 10−5, the cumulative uptake of predictive testing in the 50% at-risk UK population from 1994 to 2014 was estimated at 17.4% (95% CI: 16.9–18.0%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Future therapies in HD will likely target presymptomatic individuals; therefore, identifying the at-risk population whose gene status is unknown is of significant public health value.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Fear of health insurance loss and out-of-pocket payment for testing: North America
“After enrollment, 83 individuals [8.3%] pursued genetic testing. Their greatest concern was losing health insurance, and 41.6% of them [vs. 6.7% of those who did not pursue testing; P < 0.001] reported paying out of pocket for testing or other medical services to conceal their genetic risk from their insurer/employer.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Among individuals who were tested, more United States residents [46.1%] than Canadian residents [0.0%; P = 0.02] paid out of pocket for health services or genetic testing.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Insurance protections for genetic information in the United States
Access costs: travel, time away from work, and counseling
“Distance is a structural barrier, and relates to the time and travel required to access PT, the financial and other opportunity costs associated with taking time away from work and family to attend appointments and the stress of navigating urban centers.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Genetic counseling is necessary for presymptomatic or symptomatic HD genetic testing, but the lack of access to counseling because of geography or expense is a critical gap for many patients.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The main advantage of tele-GC was reduction in travel time for both in-person GC first (n = 16) and tele-GC first (n = 11) participants.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Testing decisions when genetic services are fully funded: Israel
Demand for predictive testing after therapeutic trial news
Reproductive genetic testing: cost-effectiveness of preimplantation genetic testing
“Cost-effectiveness analysis in a theoretical cohort of 3,851 couples, where one individual is heterozygous for Huntington disease.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“In vitro fertilization preimplantation genetic testing was associated with 77 more QALYs and a cost savings of $46,394,268.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Most notably, in our theoretical cohort of couples, IVF preimplantation genetic testing resulted in 1,079 fewer Huntington disease-affected offspring.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote